The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 22, 2019

Filed:

Sep. 29, 2017
Applicant:

Bristol-myers Squibb Company, Princeton, NJ (US);

Inventors:

Murli Krishna, Yardley, PA (US);

Alexander T. Kozhich, Princeton, NJ (US);

Martin J. Corbett, Mount Holly, NJ (US);

Zheng Lin, North Wales, PA (US);

Steven P. Piccoli, Princeton, NJ (US);

Assignee:

Bristol-Myers Squibb Company, Princeton, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/53 (2006.01); G01N 33/68 (2006.01); C07K 16/44 (2006.01);
U.S. Cl.
CPC ...
G01N 33/6854 (2013.01); C07K 16/44 (2013.01); C07K 2317/24 (2013.01); G01N 2800/52 (2013.01);
Abstract

Polyethylene glycol (PEG) is often conjugated with therapeutic proteins to enhance their PK properties. PEG may, however, be immunogenic, and the presence of PEG in food and cosmetics is believed to result in pre-existing anti-PEG antibodies in humans. Polyclonal and monoclonal antibodies reactive to PEG are provided for use in immunogenicity assay development to detect such anti-drug antibodies. Such antibodies exhibit preferential binding based on the size of PEG with molecular weight ranging from 350 daltons to 40 kD. Anti-PEG antibodies of the invention are engineered to comprise human Fc regions to enable non-bridging immunoassay formats.


Find Patent Forward Citations

Loading…